PURPOSE. The a2b1 integrin plays an important but complex role in angiogenesis and vasculopathies. Published GWAS studies established a correlation between genetic polymorphisms of the a2b1 integrin gene and incidence of diabetic retinopathy. Recent studies indicated that a2-null mice demonstrate superior vascularization in both the wound and diabetic microenvironments. The goal of this study was to determine whether the vasculoprotective effects of a2-integrin deficiency extended to the retina, using the oxygeninduced retinopathy (OIR) model for retinopathy of prematurity (ROP).METHODS. In the OIR model, wild-type (WT) and a2-null mice were exposed to 75% oxygen for 5 days (postnatal day [P] 7 to P12) and subsequently returned to room air for 6 days (P12-P18). Retinas were collected at postnatal day 7, day 13, and day 18 and examined via hematoxylin and eosin and Lectin staining. Retinas were analyzed for retinal vascular area, neovascularization, VEGF expression, and Müller cell activation. Primary Müller cell cultures from WT and a2-null mice were isolated and analyzed for hypoxia-induced VEGF-A expression.RESULTS. In the retina, the a2b1 integrin was minimally expressed in endothelial cells and strongly expressed in activated Müller cells. Isolated a2-null primary Müller cells demonstrated decreased hypoxia-induced VEGF-A expression. In the OIR model, a2-null mice displayed reduced hyperoxia-induced vaso-attenuation, reduced pathological retinal neovascularization, and decreased VEGF expression as compared to WT counterparts.CONCLUSIONS. Our data suggest that the a2b1 integrin contributes to the pathogenesis of retinopathy. We describe a newly identified role for a2b1 integrin in mediating hypoxiainduced Müller cell VEGF-A production.